FAR1-IT1

Across TCGA pan-cancer cohorts, FAR1-IT1 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of FAR1-IT1’s most consistent transcriptional readouts.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where FAR1-IT1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types FAR1-IT1 is over-expressed in tumor.

BLCA, CHOL, and KIRC are the cancer types where FAR1-IT1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in FAR1-IT1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BLCA	All	All	+0.274	.010	5	view →
CHOL	All	All	+0.131	.033	1	view →
KIRC	Male	II,III,IV	+0.075	.024	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

FAR1-IT1–BLCA

Open the BLCA breakdown →